Logo image of ECOR

ELECTROCORE INC (ECOR) Stock Price, Quote, News and Overview

NASDAQ:ECOR - Nasdaq - US28531P2020 - Common Stock - Currency: USD

6.67  -0.3 (-4.3%)

ECOR Quote, Performance and Key Statistics

ELECTROCORE INC

NASDAQ:ECOR (5/7/2025, 11:46:27 AM)

6.67

-0.3 (-4.3%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High19.49
52 Week Low5.02
Market Cap47.96M
Shares7.19M
Float5.87M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)05-07 2025-05-07/amc
IPO06-22 2018-06-22


ECOR short term performance overview.The bars show the price performance of ECOR in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 -20 -40

ECOR long term performance overview.The bars show the price performance of ECOR in the last 1, 2 and 3 years. 1 year 2 years 3 years 10 20 30 40

The current stock price of ECOR is 6.67 USD. In the past month the price increased by 22.71%. In the past year, price increased by 1.9%.

ELECTROCORE INC / ECOR Daily stock chart

ECOR Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 27.87 231.08B
ISRG INTUITIVE SURGICAL INC 69.53 190.39B
BSX BOSTON SCIENTIFIC CORP 38.71 154.59B
SYK STRYKER CORP 30.48 145.75B
MDT MEDTRONIC PLC 15.53 106.34B
BDX BECTON DICKINSON AND CO 11.73 47.46B
EW EDWARDS LIFESCIENCES CORP 28.82 44.05B
IDXX IDEXX LABORATORIES INC 41.94 38.74B
RMD RESMED INC 26.71 35.57B
DXCM DEXCOM INC 49.76 32.20B
GEHC GE HEALTHCARE TECHNOLOGY 14.91 31.39B
PHG KONINKLIJKE PHILIPS NVR- NY 15.58 22.56B

About ECOR

Company Profile

ECOR logo image electroCore, Inc. engages in the provision of non-invasive vagus nerve stimulation (nVNS) therapy. The company is headquartered in Rockaway, New Jersey and currently employs 73 full-time employees. The company went IPO on 2018-06-22. The company provides a non-invasive vagus nerve stimulation (nVNS) technology platform. The Company’s product categories include handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headache, and handheld, personal use consumer products utilizing nVNS technology to promote general wellness and human performance. Its products include gammaCore, Truvaga and TAC-STIM. Its gammaCore Sapphire is a prescription medical device that is used for a variety of primary headache conditions. Truvaga is a personal-use consumer electronics general wellness product that does not require a prescription and is available direct-to-consumer from electroCore at www.truvaga.com. TAC-STIM is a portable device that is designed specifically for use by the Military. The company stimulates the vagus nerve, only needs a few minutes to administer, and has long-lasting benefits.

Company Info

ELECTROCORE INC

200 Forge Way, Suite 205

Rockaway NEW JERSEY 07866 US

CEO: Daniel S. Goldberger

Employees: 73

ECOR Company Website

ECOR Investor Relations

Phone: 19732900097

ELECTROCORE INC / ECOR FAQ

What is the stock price of ELECTROCORE INC today?

The current stock price of ECOR is 6.67 USD. The price decreased by -4.3% in the last trading session.


What is the ticker symbol for ELECTROCORE INC stock?

The exchange symbol of ELECTROCORE INC is ECOR and it is listed on the Nasdaq exchange.


On which exchange is ECOR stock listed?

ECOR stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for ELECTROCORE INC stock?

11 analysts have analysed ECOR and the average price target is 25.7 USD. This implies a price increase of 285.37% is expected in the next year compared to the current price of 6.67. Check the ELECTROCORE INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is ELECTROCORE INC worth?

ELECTROCORE INC (ECOR) has a market capitalization of 47.96M USD. This makes ECOR a Nano Cap stock.


How many employees does ELECTROCORE INC have?

ELECTROCORE INC (ECOR) currently has 73 employees.


What are the support and resistance levels for ELECTROCORE INC (ECOR) stock?

ELECTROCORE INC (ECOR) has a support level at 6.84 and a resistance level at 7.58. Check the full technical report for a detailed analysis of ECOR support and resistance levels.


Is ELECTROCORE INC (ECOR) expected to grow?

The Revenue of ELECTROCORE INC (ECOR) is expected to grow by 29.95% in the next year. Check the estimates tab for more information on the ECOR EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy ELECTROCORE INC (ECOR) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ELECTROCORE INC (ECOR) stock pay dividends?

ECOR does not pay a dividend.


When does ELECTROCORE INC (ECOR) report earnings?

ELECTROCORE INC (ECOR) will report earnings on 2025-05-07, after the market close.


What is the Price/Earnings (PE) ratio of ELECTROCORE INC (ECOR)?

ELECTROCORE INC (ECOR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.61).


What is the Short Interest ratio of ELECTROCORE INC (ECOR) stock?

The outstanding short interest for ELECTROCORE INC (ECOR) is 5.14% of its float. Check the ownership tab for more information on the ECOR short interest.


ECOR Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to ECOR. When comparing the yearly performance of all stocks, ECOR is a bad performer in the overall market: 83.22% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

ECOR Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to ECOR. While ECOR seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ECOR Financial Highlights

Over the last trailing twelve months ECOR reported a non-GAAP Earnings per Share(EPS) of -1.61. The EPS increased by 54.78% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -58.06%
ROE -157.56%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%34.43%
Sales Q2Q%35.73%
EPS 1Y (TTM)54.78%
Revenue 1Y (TTM)57.08%

ECOR Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 84% to ECOR. The Buy consensus is the average rating of analysts ratings from 11 analysts.

For the next year, analysts expect an EPS growth of 20.36% and a revenue growth 29.95% for ECOR


Ownership
Inst Owners18.95%
Ins Owners18.26%
Short Float %5.14%
Short Ratio1.78
Analysts
Analysts83.64
Price Target25.7 (285.31%)
EPS Next Y20.36%
Revenue Next Year29.95%